Skip to content

Comparison of dualL-Trigger and hcg-Trigger on infertile patients with normal ovarian response

Comparison of two methods of dual- trigger and HCG-trigger on final oocyte maturation in infertile patients with ovarian normal response

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
IRCT
Registry ID
IRCT2015061722795N1
Enrollment
126
Registered
2016-02-01
Start date
2015-11-22
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

infertility. Female infertility associated with anovulation,Female infertility of tubal origin,Female infertility associated with male factors,Female infertility of other origin,Female infertility, unspecified,

Interventions

Intervention 1: In the intervention group for final oocyte maturation use of 5000 IU HCG intramuscular with 0.2 mg subcutaneous Decapeptyl(GNRH-agonist). Intervention 2: In the control group patient
Treatment - Drugs
In the intervention group for final oocyte maturation use of 5000 IU HCG intramuscular with 0.2 mg subcutaneous Decapeptyl(GNRH-agonist)
In the control group patients receive 10000IU HCG for final oocyte maturation

Sponsors

Tehran University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to 40 Years

Inclusion criteria

Inclusion criteria: inclusion criteria: age18-40 years;regular mense(25-34 days);BMI between 18-35;FSH days 3 =10;AMH==16 follicles on the last trans vaginal sonography );endocrine deases(DM ,hyperprolactinemia,thyroide dysfunction ,CAH,cushing syndrome);PCOs;uterine anomaly in HSG or hysteroscopy;sever male factor(azospermia require to TESE or PESA);history of OHSS;criteria of ovarian hyper response or ovarian poor response

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Number of Metaphase II oocyte. Timepoint: on oocyte retrieval day. Method of measurement: evaluation by embryologist under microscope.;Number of Metaphase II oocytse ,total number of oocytes,number of embryoss. Timepoint: oocyte retrieval day,day3 after oocyte retrieval or IVF. Method of measurement: evaluation under microscope by an embryologist and scoring by scientific evidence.

Secondary

MeasureTime frame
Biochemical pregnancy ,clinical pregnancy,abortion ,OHSS. Timepoint: two weeks after transfer for biochemical pregnancy,4weeks for clinical pregnancy,2 weeks after transfer for OHSS. Method of measurement: BHCG for biochemical ,trans vaginal sonography for clinical,clinical evaluation for OHSS.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactMarzieh Ghasemi

Tehran University of Medical Sciences,infertility ward

drghasemim@yahoo.com ghasemim841@yahoo.comghasemi-ma@razi.tums.ac.ir+98 21 84901

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026